✦ LIBER ✦

Different response to ursodeoxycholic acid (UDCA) in primary biliary cirrhosis according to severity of disease

✍ Scribed by A. Floreani; F. Zappalà; M. Mazzetto; R. Naccarato; M. Plebani; M. Chiaramonte

Book ID: 112691723
Publisher: Springer US
Year: 1994
Tongue: English
Weight: 698 KB
Volume: 39
Category: Article
ISSN: 0163-2116
DOI: 10.1007/bf02090053

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Biochemical response to ursodeoxycholic

Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis

✍ Christophe Corpechot; Ludovico Abenavoli; Nabila Rabahi; Yves Chrétien; Tony And 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 186 KB 👁 1 views

Biochemical response to ursodeoxycholic acid (UDCA) in patients with primary biliary cirrhosis (PBC) is variable. It has been recently proposed that an alkaline phosphatase (ALP) decline of more than 40% in baseline value or a normal level after 1 year of UDCA treatment (Barcelona criteria) could se

Positive responses to methotrexate and u

Positive responses to methotrexate and ursodeoxycholic acid in patients with primary biliary cirrhosis responding insufficiently to ursodeoxycholic acid alone

✍ Hans-Peter Buscher; Yvonne Zietzschmann; Wolfgang Gerok 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 471 KB

Atorvastatin in patients with primary bi

Atorvastatin in patients with primary biliary cirrhosis and incomplete biochemical response to ursodeoxycholic acid

✍ Tatjana Stojakovic; Csilla Putz-Bankuti; Günter Fauler; Hubert Scharnagl; Martin 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 207 KB 👁 1 views

Statin therapy may target both hypercholesterolemia and cholestasis in primary biliary cirrhosis (PBC). However, little is known about the efficacy and safety of statins in PBC. The aim of this single-center study was therefore to prospectively examine the effects of atorvastatin on serum markers of

Incomplete response to ursodeoxycholic a

Incomplete response to ursodeoxycholic acid in primary biliary cirrhosis: is a double dosage worthwhile?

✍ Paul Angulo; Roberta A Jorgensen; Keith D Lindor 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 155 KB

Relationship between biliary and serum b

Relationship between biliary and serum bile acids and response to ursodeoxycholic acid in patients with primary biliary cirrhosis

✍ K.D Lindor; M.A Lacerda; R.A Jorgensen; C.K DeSotel; A.K Batta; G Salen; E.R Dic 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 262 KB

Comment on biochemical response to ursod

Comment on biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis

✍ Lucy J. Walker; Julia Newton; David E. J. Jones; Margaret F. Bassendine 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

We read with interest the article by Corpechot et al. in a recent issue of HEPATOLOGY. 1 Corpechot et al. identify the absence of a biochemical response to ursodeoxycholic acid (UDCA) as an important predictive factor for death or liver transplantation in patients with primary biliary cirrhosis (PBC